CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 102 filers reported holding CYTEK BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,573,460 | +100.1% | 1,357,251 | +140.6% | 0.00% | 0.0% |
| Q1 2024 | $3,784,541 | -26.3% | 564,015 | +0.2% | 0.00% | 0.0% |
| Q4 2023 | $5,132,544 | +72.7% | 562,779 | +4.5% | 0.00% | 0.0% |
| Q3 2023 | $2,971,719 | -38.8% | 538,355 | -5.3% | 0.00% | 0.0% |
| Q2 2023 | $4,854,093 | +157.5% | 568,395 | +177.1% | 0.00% | – |
| Q1 2023 | $1,885,182 | -49.0% | 205,134 | -43.4% | 0.00% | -100.0% |
| Q4 2022 | $3,697,266 | +255059.8% | 362,122 | +267.7% | 0.00% | – |
| Q3 2022 | $1,449 | +80.4% | 98,478 | +31.5% | 0.00% | – |
| Q2 2022 | $803 | -100.0% | 74,892 | -88.5% | 0.00% | -100.0% |
| Q1 2022 | $7,000,000 | +614.3% | 649,289 | +981.1% | 0.00% | – |
| Q4 2021 | $980,000 | -34.0% | 60,060 | -13.4% | 0.00% | – |
| Q3 2021 | $1,484,000 | – | 69,322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
| Miura Global Management | 820,000 | $12,070,000 | 7.24% |
| RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
| HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
| Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
| Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
| Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
| PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
| Parkwood LLC | 42,336 | $623,000 | 0.09% |
| PDT Partners, LLC | 31,436 | $463,000 | 0.07% |